Published in Infect Immun on January 01, 1998
IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest (2000) 3.19
Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci U S A (2000) 3.07
Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev (2002) 2.79
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev (2004) 1.95
Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun (2006) 1.62
Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun (2004) 1.60
Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. Infect Immun (1999) 1.55
Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Infect Immun (2001) 1.29
Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis. Infect Immun (1998) 1.28
Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines. Infect Immun (2000) 1.24
Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis. Pulm Med (2012) 1.24
Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun (2000) 1.13
Purification and immunoreactivity of three components from the 30/32-kilodalton antigen 85 complex in Mycobacterium tuberculosis. Infect Immun (1999) 1.09
Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts. Am J Respir Crit Care Med (2005) 1.06
The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model. Infect Immun (2003) 1.01
Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm (2005) 0.99
Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin Exp Immunol (1999) 0.96
Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol (2002) 0.95
Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis. Tuberculosis (Edinb) (2008) 0.92
Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect Immun (2003) 0.91
Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages. Clin Vaccine Immunol (2007) 0.91
Roles of reactive oxygen species in CXCL8 and CCL2 expression in response to the 30-kDa antigen of Mycobacterium tuberculosis. J Clin Immunol (2008) 0.90
Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis. Infect Immun (2005) 0.90
The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis. Clin Exp Immunol (2003) 0.90
Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients. Mol Cell Proteomics (2009) 0.89
Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis. Infect Immun (2001) 0.88
Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice. Clin Exp Immunol (1998) 0.85
Comparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients. Clin Diagn Lab Immunol (2002) 0.85
Influence of Mycobacterium tuberculosis on differential activation of helper T-cells. Clin Exp Immunol (2003) 0.85
Differential effects of Radix Paeoniae Rubra (Chishao) on cytokine and chemokine expression inducible by mycobacteria. Chin Med (2011) 0.84
CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigens. Clin Diagn Lab Immunol (2005) 0.82
Human T cell and antibody-mediated responses to the Mycobacterium tuberculosis recombinant 85A, 85B, and ESAT-6 antigens. Clin Dev Immunol (2010) 0.81
Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis. Mediators Inflamm (2003) 0.81
In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis. Clin Vaccine Immunol (2008) 0.80
Human phagosome processing of Mycobacterium tuberculosis antigens is modulated by interferon-γ and interleukin-10. Immunology (2013) 0.79
Characterization of novel multiantigenic vaccine candidates with pan-HLA coverage against Mycobacterium tuberculosis. Clin Vaccine Immunol (2013) 0.79
Association of interleukin-10 cytokine expression status with HLA non-DRB1*02 and Mycobacterium bovis BCG scar-negative status in south Indian pulmonary tuberculosis patients. Infect Immun (2001) 0.79
Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis. Respiration (2010) 0.79
Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India. Med Microbiol Immunol (2009) 0.77
The viability and protein expression of Beijing/W lineage Mycobacterium tuberculosis circulating in Xinjiang, China. Curr Microbiol (2015) 0.76
Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis. Niger Med J (2013) 0.75
Regulatory T Cells and Pro-inflammatory Responses Predominate in Children with Tuberculosis. Front Immunol (2017) 0.75
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med (1993) 17.01
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med (1989) 15.15
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle (1991) 7.70
T cell response to Mycobacterium tuberculosis. J Infect Dis (1993) 5.53
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med (1996) 5.38
Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1995) 4.76
The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev (1992) 4.58
Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun (1985) 4.56
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Biological properties of interleukin 10. Immunol Today (1992) 3.62
Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol (1993) 3.51
Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol (1988) 3.14
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
IL-12: initiation cytokine for cell-mediated immunity. Science (1993) 2.97
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today (1991) 2.48
Human immune response to Mycobacterium tuberculosis antigens. Infect Immun (1991) 2.39
Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun (1995) 2.39
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity. Int Immunol (1992) 2.20
T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun (1994) 2.18
T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol (1997) 2.18
Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00
An ELISA for the serodiagnosis of tuberculosis using a 30,000-Da native antigen of Mycobacterium tuberculosis. J Infect Dis (1990) 1.65
Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect Immun (1994) 1.58
Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals. J Immunol (1995) 1.40
Purification and characterization of the 30,000 dalton native antigen of Mycobacterium tuberculosis and characterization of six monoclonal antibodies reactive with a major epitope of this antigen. J Lab Clin Med (1991) 1.31
Protein antigens of mycobacteria studied by quantitative immunologic techniques. Clin Infect Dis (1992) 1.29
Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am J Respir Crit Care Med (1994) 1.23
Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol (1994) 1.13
Deficient immune interferon production in tuberculosis. Clin Exp Immunol (1985) 1.03
Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis. Infect Immun (1993) 0.90
Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem (1999) 2.81
Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol (1994) 2.52
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A (2000) 2.23
Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun (1988) 2.21
Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol (1998) 2.14
Detection of lipoarabinomannan as a diagnostic test for tuberculosis. J Clin Microbiol (1992) 2.09
Detection of mycobacterial antigens in cerebrospinal fluid of patients with tuberculous meningitis by enzyme-linked immunosorbent assay. Lancet (1983) 1.91
Evaluation of lipoarabinomannan for the serological diagnosis of tuberculosis. J Clin Microbiol (1990) 1.89
Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber Lung Dis (1997) 1.58
Polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA in tissue and assessment of its utility in the diagnosis of hepatic granulomas. J Lab Clin Med (1996) 1.57
Diagnosis of systemic candidiasis by latex agglutination for serum antigen. J Clin Microbiol (1985) 1.56
Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol (1997) 1.50
Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis (1998) 1.34
Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J Infect Dis (1994) 1.27
Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J Immunol (2000) 1.20
Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med (1993) 1.19
Restriction endonuclease DNA analysis of Leptospira interrogans serovars Icterohaemorrhagiae and Copenhageni. Microbiol Immunol (1988) 1.17
T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J Infect Dis (1996) 1.16
Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr Res (1989) 1.16
Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol (1994) 1.13
Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber Lung Dis (1997) 1.13
Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis (1987) 1.13
The potential role of lung epithelial cells and beta-defensins in experimental latent tuberculosis. Scand J Immunol (2008) 1.10
Reactivation of human herpesvirus 6 in pityriasis rosea. Br J Dermatol (1999) 1.07
Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis. J Biol Chem (1999) 1.07
Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.06
Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes. J Immunol (1996) 1.02
Expression of transforming growth factor-beta but not tumor necrosis factor-alpha, interferon-gamma, and interleukin-4 in granulomatous lung lesions in tuberculosis. Tuber Lung Dis (2000) 1.00
Enhanced production of human immunodeficiency virus type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis (1995) 1.00
Differential activation of MAP kinase signaling pathways and nuclear factor-kappaB in bronchoalveolar cells of smokers and nonsmokers. Mol Med (2001) 0.99
Characterization of monoclonal antibodies against etiological agents of Weil's disease. Microbiol Immunol (1984) 0.93
Characterization of Leptospira strains HY-1, HY-2, and HY-10 isolated in Korea by means of monoclonal antibodies and restriction endonuclease DNA analysis. Am J Trop Med Hyg (1992) 0.93
Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood (2001) 0.92
Alveolar macrophages as accessory cells for human gamma delta T cells activated by Mycobacterium tuberculosis. J Immunol (1995) 0.91
Cell membrane is a major locus for ultraviolet B-induced alterations in accessory cells. J Clin Invest (1990) 0.88
Characterization of suppressor function of human alveolar macrophages for T lymphocyte responses to phytohemagglutinin: cellular selectivity, reversibility, and early events in T cell activation. Am J Respir Cell Mol Biol (1993) 0.87
Serological analysis of serogroup icterohaemorrhagiae using monoclonal antibodies. Microbiol Immunol (1985) 0.84
Preliminary characterization of accessory cells in the nonadherent fraction of human blood mononuclear cells. Cell Immunol (1986) 0.83
Correlation of crystal growth with the staining of axons by the Golgi procedure. Stain Technol (1967) 0.83
Accessory function of human mononuclear phagocytes for lymphocyte responses to the superantigen staphylococcal enterotoxin B. Cell Immunol (1992) 0.82
[Antagonism of pozol and Agrobacterium azotophilum on various species of bacteria and fungi, some of them pathogenic to man]. Rev Latinoam Microbiol (1976) 0.82
Evaluation of enzyme linked immunosorbent-assay and western blot for diagnosis of histoplasmosis. Rev Invest Clin (1993) 0.82
Seasonal variations in the frontal organ of the frog: structural evidence and physiological correlates. Comp Biochem Physiol A Physiol (1997) 0.81
[Description of 2 new species of bactera isolated from pozol: Agrobacterium azotophilum and Achromobacter pozolis]. Rev Latinoam Microbiol (1973) 0.81
Radiocesium accumulation in edible wild mushrooms from coniferous forests around the Nuclear Centre of Mexico. Sci Total Environ (1998) 0.80
Identification of a type V collagen-degrading enzyme from human sputum. Am Rev Respir Dis (1983) 0.80
Human herpesvirus 7 infection of lymphoid and myeloid cell lines transduced with an adenovirus vector containing the CD4 gene. J Virol (1997) 0.80
Dysregulation of beta-chemokines in the lungs of HIV-1-infected patients. J Acquir Immune Defic Syndr (2001) 0.80
[The epidemiology of dermatologic diseases in primary care]. Rev Sanid Hig Publica (Madr) (1995) 0.79
CD4 down-modulation by ganglioside and phorbol ester inhibits human herpesvirus 7 infection. J Gen Virol (1995) 0.79
Effect of acute cigarette smoking, alone or with alcohol, on gastric barrier function in healthy volunteers. Dig Liver Dis (2002) 0.78
Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte-macrophage colony-stimulating factor. Cell Immunol (2001) 0.78
Lymphocytic alveolitis in a crematorium worker. Chest (1994) 0.78
Latent infection and reactivation of human herpesvirus 6 in two novel myeloid cell lines. Blood (1999) 0.78
Asymmetry of the habenulae in the elasmobranch "Scyllium stellare". I. Light microscopy. Z Mikrosk Anat Forsch (1980) 0.77
Incorporation and activation of a membrane-bound enzyme in bilayers of liposomes. Appl Microbiol Biotechnol (1991) 0.77
Stability of Lolium perenne extract. Ann Allergy (1984) 0.77
Myelinated cell bodies in the habenular nuclei of the frog. Brain Res (1973) 0.77
Transient normalization of lymphocyte blastogenic and specific antibody responses following boosting of healthy elderly subjects with tetanus toxoid. J Gerontol (1993) 0.76
Iron metabolism by smokers' alveolar macrophages: protective or problematic in the lung? J Lab Clin Med (1988) 0.76
Adsorption equilibrium in immunoaffnity chromatography with antibodies to synthetic peptides. Biotechnol Bioeng (1990) 0.76
Central myelin in the shark Scyllium stellare (Elasmobranchii, Selachii). Z Mikrosk Anat Forsch (1983) 0.76
Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A. Am J Respir Cell Mol Biol (1997) 0.76
[Postoperative respiratory infection in esophageal cancer]. Nihon Kyobu Geka Gakkai Zasshi (1985) 0.75
Histology and ultrastructure of the dorsal habenular nuclei of the frog. Z Mikrosk Anat Forsch (1974) 0.75
Prostaglandin synthesis from arachidonic acid by immobilized ram seminal microsomes. Biotechnol Bioeng (1983) 0.75
[Microbial examination concerning the opportunity for postoperative respiratory infections in esophageal cancer]. Nihon Kyobu Geka Gakkai Zasshi (1987) 0.75
[Hepatic tuberculoma caused by Mycobacterium fortuitum. Report of a case]. Rev Invest Clin (1986) 0.75
Reaction characteristics and stability of a membrane-bound enzyme reconstituted in bilayers of liposomes. Biotechnol Bioeng (1991) 0.75
[Erythroleukemia associated with temporal arteritis]. Nihon Naika Gakkai Zasshi (1987) 0.75
[Nitrogen fixation in monospecific and mixed cultures of Aerobacter aerogenes and Agrobacterium azotophilum using different sources of carbon]. Rev Latinoam Microbiol (1976) 0.75
Effect of shear rate on activation rate of factor X. Ann Biomed Eng (1978) 0.75
Interstitial pneumopathy and low-dosage amiodarone. Eur J Respir Dis (1984) 0.75
[Identification of Leptospira responsible for Weil's disease by monoclonal antibody]. Kansenshogaku Zasshi (1983) 0.75
[A case of smoldering adult T-cell leukemia with generalized cryptococcosis]. Kansenshogaku Zasshi (1987) 0.75
[Quantitative investigation of an asymmetrical epithalamic zone in the newt and in the eel]. Boll Soc Ital Biol Sper (1971) 0.75
Measurement of enzyme reaction rates using advanced pH control system: application of repetitive PF system. Biotechnol Bioeng (1989) 0.75
Pulmonary perfusion during lung transplant rejection and experimental pneumonia. Transplantation (1992) 0.75
Elution of trypsin with an inhibitor in affinity chromatography. Biotechnol Bioeng (1979) 0.75
Arachidonic acid production by the red alga Porphyridium cruentum. Biotechnol Bioeng (1983) 0.75
A measurement of complement activity using immunoliposome. Ann N Y Acad Sci (1990) 0.75
[Clinical use of the serum level of immuno-suppressive acidic protein (IAP) in gastroenterological surgery]. Gan No Rinsho (1983) 0.75
Serological studies on Leptospira strain Ictero No. I using monoclonal antibodies. Microbiol Immunol (1991) 0.75
[Pancreatic cystic fibrosis in Mexicans over 15 years of age]. Rev Invest Clin (1991) 0.75
Superficial and deep blood vessel distribution in the frog telencephalon. Reference to morphological brain asymmetries. Z Mikrosk Anat Forsch (1990) 0.75
Improvement of proteolytic resistance of immunoadsorbents by chemical modification with polyethylene glycol. Biotechnol Bioeng (1989) 0.75
[Analysis of immunological characteristics of serogroup icterohaemorrhagiae using monoclonal antibodies]. Kansenshogaku Zasshi (1988) 0.75
[A simple method of reducing irradiation of the patient and improving the results of xerotomography in pulmonary diagnostics: "aimed" xerotomography]. Radiol Med (1982) 0.75
[Modified Hill's operation in sliding hiatal hernia and intraoperative esophageal pressure]. Nihon Kyobu Geka Gakkai Zasshi (1983) 0.75
Structural, ultrastructural and immunohistochemical observations on the interpeduncular nucleus of the elasmobranch fish Scyllium stellare. Z Mikrosk Anat Forsch (1986) 0.75
Entrapment of an ion-dependent enzyme into reverse-phase evaporation vesicles. Biotechnol Bioeng (1988) 0.75
[Regression of sarcoidosic hilo-mediastinal adenopathy after radiotherapy]. Minerva Radiol (1965) 0.75